A Study Of Insomnia

The Efficacy Of Shankhapushpi Kwath Dhara And Shankhapushpi Vati In Nidranash With Special Reference to Manovaha Strotodushti A Randomised Comparative Study - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108754

Enrollment

Registered

2026-04-20

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F519- Sleep disorder not due to a substance or known physiological condition, unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients diagnosed with nidranasha based on ayurvedic and DSM 5 criteria of insomnia. 2.Age group 20 to 60 years. 3.Duration of insomnia maximum 3 months and less than 12 months. 4.insomnia severity index between 15 and 25.

Exclusion criteria

Exclusion criteria: 1.Patients with secondary insomnia due to systemic illlness. 2.Known psychiatric disorders. 3.History of substance abuse or alcohol dependence. 4.Ongoing use of sleep medications or sedatives. 5.Pregnant or lactating women. 6.Indivisuals with neurological or endocrine disorders.

Design outcomes

Primary

Measure	Time frame
Significant improvement in subjective and objective sleep parameters such as sleep latency,duration,and continuity,particularly in the combination groupTimepoint: in 21 days of treatment	—

Secondary

Measure	Time frame
1.Comparative efficacy. 2.reduction in symptoms of manovaha srotodushti. 3.Validation role of Shankhapushpi in nidranash. Timepoint: In 21 days of treatment.	—

Countries

India

Contacts

Public ContactDr Akash Verma

Pt Dr Shivshaktilal Sharma Ayurvedic Medical College Ratlam

drumeshshukla11@gmail.com9425362622

Outcome results